Top

CardioVascular and Interventional Radiology

Published in:

01-10-2015 | Clinical Investigation

Initial Results of Image-Guided Percutaneous Ablation as Second-Line Treatment for Symptomatic Vascular Anomalies

Authors: Scott M. Thompson, Matthew R. Callstrom, Michael A. McKusick, David A. Woodrum

Published in: CardioVascular and Interventional Radiology | Issue 5/2015

Abstract

Purpose

The purpose of this study was to determine the feasibility, safety, and early effectiveness of percutaneous image-guided ablation as second-line treatment for symptomatic soft-tissue vascular anomalies (VA).

Materials and Methods

An IRB-approved retrospective review was undertaken of all patients who underwent percutaneous image-guided ablation as second-line therapy for treatment of symptomatic soft-tissue VA during the period from 1/1/2008 to 5/20/2014. US/CT- or MRI-guided and monitored cryoablation or MRI-guided and monitored laser ablation was performed. Clinical follow-up began at one-month post-ablation.

Results

Eight patients with nine torso or lower extremity VA were treated with US/CT (N = 4) or MRI-guided (N = 2) cryoablation or MRI-guided laser ablation (N = 5) for moderate to severe pain (N = 7) or diffuse bleeding secondary to hemangioma–thrombocytopenia syndrome (N = 1). The median maximal diameter was 9.0 cm (6.5–11.1 cm) and 2.5 cm (2.3–5.3 cm) for VA undergoing cryoablation and laser ablation, respectively. Seven VA were ablated in one session, one VA initially treated with MRI-guided cryoablation for severe pain was re-treated with MRI-guided laser ablation due to persistent moderate pain, and one VA was treated in a planned two-stage session due to large VA size. At an average follow-up of 19.8 months (range 2–62 months), 7 of 7 patients with painful VA reported symptomatic pain relief. There was no recurrence of bleeding at five-year post-ablation in the patient with hemangioma–thrombocytopenia syndrome. There were two minor complications and no major complications.

Conclusion

Image-guided percutaneous ablation is a feasible, safe, and effective second-line treatment option for symptomatic VA.

Lowe LH, Marchant TC, Rivard DC, Scherbel AJ (2012) Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol 47(2):106–117CrossRefPubMed

Kelly M (2010) Kasabach-Merritt phenomenon. Pediatr Clin North Am 57(5):1085–1089CrossRefPubMed

van der Vleuten CJ, Kater A, Wijnen MH, Schultze Kool LJ, Rovers MM (2014) Effectiveness of sclerotherapy, surgery, and laser therapy in patients with venous malformations: a systematic review. Cardiovasc Intervent Radiol 37(4):977–989PubMed

Kim AH, Ko HK, Won JY, Lee do Y (2009) Percutaneous radiofrequency ablation: a novel treatment of facial venous malformation. J Vasc Surg 50(2):424–427CrossRefPubMed

Childs DD, Emory CL (2012) Successful treatment of intramuscular venous malformation with image-guided radiofrequency ablation. J Vasc Interv Radiol 23(10):1391–1393CrossRefPubMed

Cornelis F, Neuville A, Labreze C et al (2013) Percutaneous cryotherapy of vascular malformation: initial experience. Cardiovasc Intervent Radiol 36(3):853–856CrossRefPubMed

Cornelis F, Havez M, Labreze C et al (2013) Percutaneous cryoablation of symptomatic localized venous malformations: preliminary short-term results. J Vasc Interv Radiol 24(6):823–827CrossRefPubMed

Flors L, Leiva-Salinas C, Maged IM et al (2011) MR imaging of soft-tissue vascular malformations: diagnosis, classification, and therapy follow-up. Radiographics 31(5):1321–1340 discussion 1340-1321CrossRefPubMed

Woodrum DA, Kawashima A, Karnes RJ et al (2013) Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience. Urology 82(4):870–875CrossRefPubMed

10.

Woodrum DA, Mynderse LA, Gorny KR, Amrami KK, McNichols RJ, Callstrom MR (2011) 3.0T MR-guided laser ablation of a prostate cancer recurrence in the postsurgical prostate bed. J Vasc Interv Radiol 22(7):929–934CrossRefPubMed

11.

Sacks D, McClenny TE, Cardella JF, Lewis CA (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14(9 Pt 2):S199–S202CrossRefPubMed

12.

Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided Tumor Ablation: standardization of Terminology and Reporting Criteria-A 10-Year Update. Radiology 273(1):241–260CrossRefPubMedPubMedCentral

13.

Gloviczki P, Duncan A, Kalra M et al (2009) Vascular malformations: an update. Perspect Vasc Surg Endovasc Ther 21(2):133–148CrossRefPubMed

14.

Alomari A, Dubois J (2011) Interventional management of vascular malformations. Tech Vasc Interv Radiol 14(1):22–31CrossRefPubMed

15.

Gurgacz S, Zamora L, Scott NA (2014) Percutaneous sclerotherapy for vascular malformations: a systematic review. Ann Vasc Surg 28(5):1335–1349CrossRefPubMed

16.

Blatt J, McLean TW, Castellino SM, Burkhart CN (2013) A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations. Pharmacol Ther 139(3):327–333CrossRefPubMed

17.

Enjolras O, Mulliken JB, Wassef M et al (2000) Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 42(2 Pt 1):225–235CrossRefPubMed

18.

Kurup AN, Morris JM, Schmit GD et al (2013) Neuroanatomic considerations in percutaneous tumor ablation. Radiographics 33(4):1195–1215CrossRefPubMed

19.

Philip A, Gupta S, Ahrar K, Tam AL (2013) A spectrum of nerve injury after thermal ablation: a report of four cases and review of the literature. Cardiovasc Intervent Radiol 36(5):1427–1435CrossRefPubMed

20.

Buy X, Tok CH, Szwarc D, Bierry G, Gangi A (2009) Thermal protection during percutaneous thermal ablation procedures: interest of carbon dioxide dissection and temperature monitoring. Cardiovasc Intervent Radiol 32(3):529–534CrossRefPubMed

21.

Tsoumakidou G, Garnon J, Ramamurthy N, Buy X, Gangi A (2013) Interest of electrostimulation of peripheral motor nerves during percutaneous thermal ablation. Cardiovasc Intervent Radiol 36(6):1624–1628CrossRefPubMed

22.

Kurup AN, Morris JM, Boon AJ et al (2014) Motor Evoked Potential Monitoring during Cryoablation of Musculoskeletal Tumors. J Vasc Interv Radiol 25(11):1657–1664CrossRefPubMed

Title: Initial Results of Image-Guided Percutaneous Ablation as Second-Line Treatment for Symptomatic Vascular Anomalies
Authors: Scott M. Thompson
Matthew R. Callstrom
Michael A. McKusick
David A. Woodrum
Publication date: 01-10-2015
Publisher: Springer US
Published in: CardioVascular and Interventional Radiology / Issue 5/2015
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-015-1079-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Initial Results of Image-Guided Percutaneous Ablation as Second-Line Treatment for Symptomatic Vascular Anomalies

Abstract

Purpose

Materials and Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Materials and Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2015

Image-Guided Cryoablation of the Spine in a Swine Model: Clinical, Radiological, and Pathological Findings with Light and Electron Microscopy

Patient Compliance with Surveillance Following Elective Endovascular Aneurysm Repair

Erratum to: Cone Beam Computed Tomography (CBCT) in the Field of Interventional Oncology of the Liver

Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts

Retained Short Hook Wires Used for Preoperative Localization of Small Pulmonary Lesions During Video-Assisted Thoracoscopic Surgery: A Report of 2 Cases

T-Stenting-and-Small-Protrusion Technique for Bifurcation Stenoses After End-to-Side Anastomosis of Transplant Renal Artery and External Iliac Artery: Report of Two Cases